LBF20207PG67
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1747 |
LipidMaps | LMFA03010065 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG67 |
16,16-dimethyl Prostaglandin E2 | |
---|---|
Structural Information | |
9-Oxo- (11α,15R) -dihydroxy-16,16-dimethyl-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C22H36O5 |
Exact Mass | 380.256274262 |
Average Mass | 380.51824000000005 |
SMILES | [C@@H]([C@@H]1C=C[C@@H](C(CCCC)(C)C)O)(CC(=O)[C@@H]1CC=CCCCC(O)=O)O |
Physicochemical Information | |
16,16-dimethyl Prostaglandin E2 shows cervical ripening and uterine constriction and consequent inhibition of ulcer formation. Robert_A et al. Coleman_RA et al. 16,16-dimethyl Prostaglandin E2 increases eNOS mRNA expression of adult microvessels to values in the newborn pig. Dumont_I et al. 16,16-dimethyl Prostaglandin E2 prevents indomethacin-induced gastric lesions. Suzuki_K et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|